4-hydroxyacetophenone has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arrieta, J; Pineda-Farías, JB; Rivero-Cruz, JF; Rocha-González, HI; Rodríguez-Silverio, J; Sánchez-Mendoza, ME | 1 |
| Ching-Wen, C; Wen-Huang, P; Yu-Chin, L; Yun-Chieh, C | 1 |
2 other study(ies) available for 4-hydroxyacetophenone and Disease Models, Animal
| Article | Year |
|---|---|
Antinociceptive effect and gastroprotective mechanisms of 3,5-diprenyl-4-hydroxyacetophenone from Ageratina pichinchensis.
Topics: Acetophenones; Ageratina; Analgesics; Animals; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Gastrointestinal Agents; Inflammation; Ligation; Male; Neuralgia; Nitric Oxide; Phytotherapy; Plant Extracts; Plant Leaves; Prostaglandins; Rats; Rats, Wistar; Spinal Nerves; Stomach Ulcer; Sulfhydryl Compounds | 2013 |
p-Hydroxyacetophenone suppresses nuclear factor-κB-related inflammation in nociceptive and inflammatory animal models.
Topics: Acetophenones; Analgesics; Animals; Anti-Inflammatory Agents; Artemisia; Biological Products; Disease Models, Animal; Inflammation; Liver; Male; Mice; NF-kappa B; Nitric Oxide; Plant Extracts | 2017 |